Basic Health Unit, Hersa Sheikh, Chiniot, University Medical and Dental College, Faisalabad, Pakistan.
Dental Section, Punjab Medical College, Faisalabad, Pakistan.
Complement Ther Med. 2022 Oct;69:102845. doi: 10.1016/j.ctim.2022.102845. Epub 2022 Jun 6.
This systematic review and meta-analysis were aimed to determine the effects of grape products on liver enzymes in adults.
Databases including PubMed/Medline, Cochrane Library, ISI Web of Science, and Scopus were searched up to February 2021. Randomized clinical trials (RCTs) investigating the effect of grape products on serum concentrations of liver enzymes were included. Data were pooled using the random-effects model and weighted mean difference (WMD) was considered as the summary effect size.
Eight RCTs enrolling 291 participants met the inclusion criteria for this meta-analysis. The overall effect illustrated no significant change in serum levels of alanine aminotransferase (ALT) (WMD: - 2.04; 95 % CI: - 5.50 to 1.42; P = 0.24; I = 72.5 %), and aspartate aminotransferase (AST) (WMD: - 1.40; 95 % CI: - 3.80 to 0.99; P = 0.25; I = 76.0 %) in intervention group compared with the control group. Subgroup analyses revealed that the effect of grape products on ALT (WMD: - 4.97; 95 % CI: - 8.73 to - 1.21; P = 0.01) and AST (WMD: - 2.89; 95 % CI: - 5.69 to - 0.08; P = 0.04) levels was significant when the intervention period was equal or more than 12 weeks.
Overall, grape products had no significant effect on liver enzymes in adults. However, due to the low number of included studies, these findings must be interpreted with great caution. Larger, well-designed RCTs are still needed to further evaluate the capacity of the grape products as a complementary treatment to improve liver enzymes.
本系统评价和荟萃分析旨在确定葡萄产品对成年人肝酶的影响。
检索了包括 PubMed/Medline、Cochrane 图书馆、ISI Web of Science 和 Scopus 在内的数据库,检索时间截至 2021 年 2 月。纳入了研究葡萄产品对血清肝酶浓度影响的随机临床试验(RCT)。使用随机效应模型汇总数据,并将加权均数差(WMD)视为汇总效应量。
纳入了 8 项 RCT,共 291 名参与者符合本荟萃分析的纳入标准。总体效应表明,干预组与对照组相比,血清丙氨酸氨基转移酶(ALT)水平(WMD:-2.04;95%CI:-5.50 至 1.42;P=0.24;I=72.5%)和天冬氨酸氨基转移酶(AST)水平(WMD:-1.40;95%CI:-3.80 至 0.99;P=0.25;I=76.0%)无显著变化。亚组分析显示,当干预时间等于或大于 12 周时,葡萄产品对 ALT(WMD:-4.97;95%CI:-8.73 至-1.21;P=0.01)和 AST(WMD:-2.89;95%CI:-5.69 至-0.08;P=0.04)水平的影响具有统计学意义。
总体而言,葡萄产品对成年人的肝酶无显著影响。然而,由于纳入研究数量较少,这些发现必须谨慎解释。仍需要更大、设计良好的 RCT 来进一步评估葡萄产品作为改善肝酶的辅助治疗的能力。